{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:33:36Z","timestamp":1783499616914,"version":"3.55.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["17K08438"],"award-info":[{"award-number":["17K08438"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0214037","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T13:30:37Z","timestamp":1568381437000},"page":"e0214037","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of a rifampicin pre-treatment on linezolid pharmacokinetics"],"prefix":"10.1371","volume":"14","author":[{"given":"Fumiyasu","family":"Okazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-2947","authenticated-orcid":true,"given":"Yasuhiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Ogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"issue":"1","key":"pone.0214037.ref001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/PL00012242","article-title":"Linezolid, critical characteristics","volume":"28","author":"JC Hamel","year":"2000","journal-title":"Infection"},{"issue":"3","key":"pone.0214037.ref002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0149-2918(01)80043-6","article-title":"Linezolid: an oxazolidinone antimicrobial agent","volume":"23","author":"HB Fung","year":"2001","journal-title":"Clinical therapeutics"},{"issue":"8","key":"pone.0214037.ref003","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archinte.168.8.805","article-title":"Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature","volume":"168","author":"J Perlroth","year":"2008","journal-title":"Archives of internal medicine"},{"issue":"1","key":"pone.0214037.ref004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00034-09","article-title":"Rifampin combination therapy for nonmycobacterial infections","volume":"23","author":"GN Forrest","year":"2010","journal-title":"Clinical microbiology reviews"},{"issue":"1","key":"pone.0214037.ref005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.7326\/0003-4819-85-1-82","article-title":"Rifampin","volume":"85","author":"WE Sanders","year":"1976","journal-title":"Annals of internal medicine"},{"issue":"3","key":"pone.0214037.ref006","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/AAC.00740-10","article-title":"Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis","volume":"55","author":"P Vergidis","year":"2011","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"9","key":"pone.0214037.ref007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jiac.2014.05.008","article-title":"Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides","volume":"20","author":"C Cabellos","year":"2014","journal-title":"Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy"},{"issue":"7","key":"pone.0214037.ref008","doi-asserted-by":"crossref","first-page":"e101311","DOI":"10.1371\/journal.pone.0101311","article-title":"Analysis of combination drug therapy to develop regimens with shortened duration of treatment for tuberculosis","volume":"9","author":"GL Drusano","year":"2014","journal-title":"PloS one"},{"issue":"2","key":"pone.0214037.ref009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0091270010366445","article-title":"Unexpected effect of rifampin on the pharmacokinetics of linezolid: in silico and in vitro approaches to explain its mechanism","volume":"51","author":"K Gandelman","year":"2011","journal-title":"Journal of clinical pharmacology"},{"issue":"5","key":"pone.0214037.ref010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jiac.2015.11.012","article-title":"Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring","volume":"22","author":"N Ashizawa","year":"2016","journal-title":"Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy"},{"issue":"8","key":"pone.0214037.ref011","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/bcp.13262","article-title":"Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients","volume":"83","author":"Y Tsuji","year":"2017","journal-title":"British journal of clinical pharmacology"},{"issue":"6","key":"pone.0214037.ref012","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"JL Staudinger","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1\u20133","key":"pone.0214037.ref013","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbalip.2004.11.003","article-title":"Novel pathways of bile acid metabolism involving CYP3A4","volume":"1687","author":"K Bodin","year":"2005","journal-title":"Biochimica et biophysica acta"},{"issue":"3","key":"pone.0214037.ref014","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/mp300512r","article-title":"PXR\/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein","volume":"10","author":"N Holmstock","year":"2013","journal-title":"Molecular pharmaceutics"},{"issue":"9","key":"pone.0214037.ref015","first-page":"1014","article-title":"Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes","volume":"28","author":"MA Wynalda","year":"2000","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"5","key":"pone.0214037.ref016","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.clpt.2005.01.020","article-title":"Linezolid and rifampin: Drug interaction contrary to expectations?","volume":"77","author":"H Egle","year":"2005","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"5","key":"pone.0214037.ref017","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2885.2004.00607.x","article-title":"Therapeutic implications of the MDR-1 gene","volume":"27","author":"KL Mealey","year":"2004","journal-title":"Journal of veterinary pharmacology and therapeutics"},{"issue":"4","key":"pone.0214037.ref018","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/dmd.104.002485","article-title":"Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line","volume":"33","author":"R Tian","year":"2005","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"9","key":"pone.0214037.ref019","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/AAC.00486-13","article-title":"Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells","volume":"57","author":"GN Chan","year":"2013","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"pone.0214037.ref020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40262-015-0314-y","article-title":"Drug-Drug Interactions with the NS3\/4A Protease Inhibitor Simeprevir","volume":"55","author":"S Ouwerkerk-Mahadevan","year":"2016","journal-title":"Clinical pharmacokinetics"},{"issue":"21","key":"pone.0214037.ref021","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1158\/0008-5472.CAN-15-1454","article-title":"Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models","volume":"75","author":"AK MacLeod","year":"2015","journal-title":"Cancer research"},{"issue":"Suppl 2","key":"pone.0214037.ref022","first-page":"ii17","article-title":"Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections","volume":"51","author":"AP MacGowan","year":"2003","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"8","key":"pone.0214037.ref023","first-page":"1136","article-title":"Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects","volume":"29","author":"JG Slatter","year":"2001","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0214037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:22:28Z","timestamp":1588980148000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0214037"}},"subtitle":[],"editor":[{"given":"Jed N.","family":"Lampe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0214037","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/572610","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]}}}